Skip to content

Clinical trials

Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 2 Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20061
20071
20083
20091
20101
20123
20132
20151
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Active, not recruiting2
Not yet recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology2
Biogen2
NCIC Clinical Trials Group2
University Health Network, Toronto2
AbbVie1
British Columbia Cancer Agency1
Canadian Cancer Trials Group1
CancerCare Manitoba1
Celgene1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell24
Lymphoma, Follicular5
Leukemia4
Lymphoma4
Lymphoma, Mantle-Cell4
Lymphoma, Non-Hodgkin3
Recurrence3
Burkitt Lymphoma2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Large B-Cell, Diffuse2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.